Calithera Biosciences, Inc. (CALA) Q4 2021 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by and welcome to Calathera Biosciences' fourth quarter 2021 earnings call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1 on your telephone. Please be advised that today's call is being recorded. Should you require any further assistance, please press star 0. I would now like to hand the call over to Stephanie Wong, Chief Financial Officer. Please go ahead. Thank you, Operator. Good afternoon, everyone. Welcome to our fourth quarter and full year 2021 conference call. Joining me today are Susan Molyneux, Founder, President, and CEO, and Emil Kuryakov, Chief Medical Officer. Earlier this afternoon, we issued a press release which included an overview of our fourth quarter and full year 2021 financial and operational results which can be accessed through our website at calathera.com. Before we begin, I would like to remind you that today's discussion will include statements about our future expectations, plans, and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those discussed in the risk factors section of our periodic filings with the SEC. In addition, forward-looking statements represent our views only as of today and should not be relied upon as representing our views as of any subsequent date. While we may elect to update these forward-looking statements at some point in the future, we specifically disclaim any obligation to do so even if...